3
Disclosures
Jan 14, 2026 — Mar 17, 2026
Date Range
PRIME
Market Segment

Disclosures

DateTypeHeadlinePDF
Mar 17 Earnings CellSource: Reports Q1 Revenue of 860 million, Up 1% PDF
Mar 17 Other CellSource: Reports Q1 Revenue Increase Driven by Orthopedic Support Services PDF
Mar 17 Other CellSource: Approved for Tokyo SE Standard Market Transfer PDF

Disclosure Types

Other: 2 Earnings: 1